Cardiology is the study of diseases and abnormalities of the heart and cardiovascular tissue, playing an integral role in many intersecting fields of medicine. With 1 in every 4, cardiovascular disease is the leading cause of death for both men and women in the U.S. (CDC)

Hereditary Transthyretin Amyloidosis: Addressing Barriers to Diagnosis and Evolving Disease Management
Identify the neurologic, autonomic, cardiac symptoms of hATTR amyloidosis in the context of the differential diagnosis for hATTR amyloidosis
CME: 1.0
Bleeding Risk Assessment and Management in Patients Receiving Anticoagulation
Apply clinical standard of care in the management of bleeding from access to selective anticoagulation reversal agents to effective overall supportive bleeding management strategies
CME: 1.0
Medical Crossfire®: Hot Topics in Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors (PCSK9i)
Describe the latest clinical guidelines and recommendations for the use of proprotein convertase subtilisin kexin type 9 inhibitors (PCKS9i)
CME: 1.5
How and When to Consider a PCSK9 Inhibitor in Practice
Review the latest clinical trial data on PCSK9 inhibitors in reducing cardiovascular events in patients with hypercholesterolemia.
CME: 0.5
Getting to the Heart of Type 2 Diabetes Management: Practice Insights for Nurse Practitioners and Physician Assistants
Using a case-based approach, apply CVOT data and current guideline recommendations to individualize glucose lowering therapy and reduce cardiovascular risk in patients with T2D.
CME: 1.0
Can We Do It Better: Improving Outcomes in Patients with Atrial Fibrillation
Select appropriate AF patients for rate, rhythm, or ablation therapy in accordance with current guideline recommendations to optimize outcomes.
CME: 0.5
A Virtual Reality Tour of Nonstatin LDL-C-lowering Agents that Decrease Cardiovascular Risk for Patients with Persistent Hypercholesterolemia
Discuss the latest clinical trial data available on nonstatin LDL-C–lowering agents and their position in treatment regimens for patients with elevated LDL-C levels
CME: 1.0
Updates in ACS Management: Applying Clinical Trial Data and Guideline Recommendations to Individualize Duration of Dual Antiplatelet Therapy
Examine recent clinical data and ACC/AHA guideline updates regarding the optimal use and duration of dual antiplatelet therapy (DAPT) in acute coronary syndromes (ACS).
CME: 1.0
Managing Risk in a Patient with Recent ACS
Discuss modalities of therapeutic interventions to lower Lp(a) levels in plasma while evaluating the clinical effects, safety, and efficacy data for treatment options for LDL receptor disorders.
CME: 0.5